Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and Tisagenlecleucel
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-2027
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and Tisagenlecleucel ; volume:39 ; number:9 ; day:7 ; month:7 ; year:2021 ; pages:1021-1044 ; date:9.2021
PharmacoEconomics ; 39, Heft 9 (7.7.2021), 1021-1044, 9.2021
- Creator
-
Facey, Karen M.
Espin, Jaime
Kent, Emma
Link, Angèl
Nicod, Elena
O’Leary, Aisling
Xoxi, Entela
Vijver, Inneke van de
Zaremba, Anna
Benisheva, Tatyana
Vagoras, Andrius
Upadhyaya, Sheela
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40273-021-01050-5
- URN
-
urn:nbn:de:101:1-2021103110193933912655
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Facey, Karen M.
- Espin, Jaime
- Kent, Emma
- Link, Angèl
- Nicod, Elena
- O’Leary, Aisling
- Xoxi, Entela
- Vijver, Inneke van de
- Zaremba, Anna
- Benisheva, Tatyana
- Vagoras, Andrius
- Upadhyaya, Sheela
- SpringerLink (Online service)
Other Objects (12)
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications
Implementing international environmental agreements in Russia
Implementing international environmental agreements in Russia
Impact of Managed Entry Agreements on availability of and timely access to medicines: an ex-post evaluation of agreements implemented for oncology therapies in four countries
The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment
Managed Entry Agreements for High-Cost, One-Off Potentially Curative Therapies: A Framework and Calculation Tool to Determine Their Suitability
Implementing Pre-Emptive Managed Retreat: Constraints and Novel Insights
Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries
The game of negotiations: Ordering issues and implementing agreements
Managed decline? Muddling through with the sterling (dis)agreements, 1968-74
Implementing a successful data-management framework: the UK10K managed access model
The challenge of implementing the overlapping regional trade agreements in Egypt
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications
Implementing international environmental agreements in Russia
Implementing international environmental agreements in Russia
Impact of Managed Entry Agreements on availability of and timely access to medicines: an ex-post evaluation of agreements implemented for oncology therapies in four countries
The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment
Managed Entry Agreements for High-Cost, One-Off Potentially Curative Therapies: A Framework and Calculation Tool to Determine Their Suitability
Implementing Pre-Emptive Managed Retreat: Constraints and Novel Insights
Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries
The game of negotiations: Ordering issues and implementing agreements
Managed decline? Muddling through with the sterling (dis)agreements, 1968-74
Implementing a successful data-management framework: the UK10K managed access model
The challenge of implementing the overlapping regional trade agreements in Egypt
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications
Implementing international environmental agreements in Russia
Implementing international environmental agreements in Russia
Impact of Managed Entry Agreements on availability of and timely access to medicines: an ex-post evaluation of agreements implemented for oncology therapies in four countries
The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment
Managed Entry Agreements for High-Cost, One-Off Potentially Curative Therapies: A Framework and Calculation Tool to Determine Their Suitability
Implementing Pre-Emptive Managed Retreat: Constraints and Novel Insights
Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries
The game of negotiations: Ordering issues and implementing agreements
Managed decline? Muddling through with the sterling (dis)agreements, 1968-74
Implementing a successful data-management framework: the UK10K managed access model